Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/25433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKoshy, Anoop N-
dc.contributor.authorGow, Paul J-
dc.contributor.authorHan, Hui-Chen-
dc.contributor.authorTeh, Andrew W-
dc.contributor.authorLim, Han S-
dc.contributor.authorTestro, Adam G-
dc.contributor.authorJones, Robert M-
dc.contributor.authorFarouque, Omar-
dc.date2020-11-27-
dc.date.accessioned2020-12-06T21:53:55Z-
dc.date.available2020-12-06T21:53:55Z-
dc.date.issued2020-11-27-
dc.identifier.citationInternational Journal of Cardiology 2020; online first: 27 Novemberen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/25433-
dc.description.abstractCardiovascular events are a leading cause of mortality following liver transplantation (LT). Although a preponderance of sudden cardiac death (SCD) in this population has been reported, there is a paucity of data evaluating the incidence, timing and predictors of SCD following LT. Using the prospectively collected Australian and New Zealand Liver Transplant Registry, a cohort study of all adult LTs from 1985 to 2017 was performed to ascertain the incidence and predictors of SCD. Recipient cause of death was adjudicated by an interdisciplinary panel. 4265 LT patients were followed-up for 37,409 person-years. SCD was the leading mode of cardiovascular death with an incidence rate of 165 per 100,000 person-years. There was a significant increase in the hazard of SCD in the contemporary (1996-2017) vs early era (1985-1995) (hazard ratio [HR] 2.42, 95%CI 1.10-5.40; p = 0.02). On Cox regression after adjusting for significant univariate predictors including age, coronary artery disease and non-alcoholic steatohepatitis, pre-transplant diabetes was the only independent predictor of SCD (HR 2.5 95%CI 1.1-6.0). SCD is the leading mode of cardiovascular cause-specific mortality following LT and diabetes was associated with a two-fold higher risk for its occurrence. Given the escalating cardiovascular risk factor profile of LT candidates, targeted therapies especially in patients with diabetes are needed to mitigate risk of post-transplant SCD.en
dc.language.isoeng
dc.subjectCardiac arresten
dc.subjectCardiovascular mortalityen
dc.subjectLiver cirrhosisen
dc.subjectLiver transplantationen
dc.subjectNon-alcoholic fatty liver diseaseen
dc.subjectSudden cardiac deathen
dc.titleSudden cardiac death following liver transplantation: Incidence, trends and risk predictors.en
dc.typeJournal Articleen
dc.identifier.journaltitleInternational Journal of Cardiologyen
dc.identifier.affiliationCardiologyen
dc.identifier.affiliationVictorian Liver Transplant Uniten
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Victoria, Australia.en
dc.identifier.doi10.1016/j.ijcard.2020.11.038en
dc.type.contentTexten
dc.identifier.pubmedid33253736
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Apr 16, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.